Just to take Vaxxinia to end of phase 2 will cost $22.5m for patient cost alone. $4.5m for cohort of 30 in phase 1. Then $18m for cohort of 100-120 in phase1/2. CheckVacc has another 15-20 patients going into phase 1 ($3m cost).
The amount that is riding on the hervaxx data readout is enormous for shareholders.
Ann: Appendix 4C - quarterly, page-44
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $382.1K | 7.853M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 8072405 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 668099 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |